A quantitative systems pharmacology model of colonic motility with applications in drug development.


Journal

Journal of pharmacokinetics and pharmacodynamics
ISSN: 1573-8744
Titre abrégé: J Pharmacokinet Pharmacodyn
Pays: United States
ID NLM: 101096520

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 02 01 2019
accepted: 09 08 2019
pubmed: 23 8 2019
medline: 19 5 2020
entrez: 22 8 2019
Statut: ppublish

Résumé

We developed a mathematical model of colon physiology driven by serotonin signaling in the enteric nervous system. No such models are currently available to assist drug discovery and development for GI motility disorders. Model parameterization was informed by published preclinical and clinical data. Our simulations provide clinically relevant readouts of bowel movement frequency and stool consistency. The model recapitulates healthy and slow transit constipation phenotypes, and the effect of a 5-HT

Identifiants

pubmed: 31432345
doi: 10.1007/s10928-019-09651-6
pii: 10.1007/s10928-019-09651-6
doi:

Substances chimiques

Serotonin Receptor Agonists 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

485-498

Références

Gastroenterology. 2001 Feb;120(2):354-60
pubmed: 11159875
Best Pract Res Clin Gastroenterol. 2016 Apr;30(2):145-59
pubmed: 27086882
Aliment Pharmacol Ther. 2002 Apr;16(4):759-67
pubmed: 11929394
Am J Physiol. 1992 Feb;262(2 Pt 1):G298-307
pubmed: 1371648
CPT Pharmacometrics Syst Pharmacol. 2015 Mar;4(3):e00020
pubmed: 26225239
Prog Neurobiol. 2004 Feb;72(2):143-64
pubmed: 15063530
Gastroenterology. 2012 Apr;142(4):844-854.e4
pubmed: 22226658
Dig Dis Sci. 1994 Jul;39(7):1558-64
pubmed: 8026270
Gut. 1988 Sep;29(9):1173-9
pubmed: 3197990
CPT Pharmacometrics Syst Pharmacol. 2019 Jun;8(6):336-339
pubmed: 30924594
Aliment Pharmacol Ther. 2000 Apr;14(4):471-7
pubmed: 10759627
Nat Rev Gastroenterol Hepatol. 2013 Aug;10(8):473-86
pubmed: 23797870
Neurology. 2016 Mar 15;86(11):1014-21
pubmed: 26888980
J Wound Ostomy Continence Nurs. 1999 May;26(3):137-41
pubmed: 10711123
Clin Exp Gastroenterol. 2010;3:49-56
pubmed: 21694846
Eur J Gastroenterol Hepatol. 2001 Apr;13(4):441-8
pubmed: 11338078
Gastroenterology. 1962 May;42:535-46
pubmed: 14459301
World J Gastroenterol. 2006 Aug 7;12(29):4609-13
pubmed: 16937428
N Engl J Med. 2008 May 29;358(22):2344-54
pubmed: 18509121
Gut. 1987 Jan;28(1):17-25
pubmed: 3817580
Prog Biophys Mol Biol. 2014 Sep;116(1):56-69
pubmed: 25238716
Br J Pharmacol. 1995 Apr;114(8):1525-7
pubmed: 7599919
CPT Pharmacometrics Syst Pharmacol. 2018 Mar;7(3):135-146
pubmed: 29349875
Front Pharmacol. 2011 May 30;2:25
pubmed: 21687517
Gastroenterology. 2013 Feb;144(2):314-322.e2
pubmed: 23142135
Am J Physiol Gastrointest Liver Physiol. 2009 Dec;297(6):G1107-14
pubmed: 19808653
N Engl J Med. 2003 Oct 2;349(14):1360-8
pubmed: 14523145
Aliment Pharmacol Ther. 1999 Nov;13(11):1493-7
pubmed: 10571606
Aliment Pharmacol Ther. 2014 Feb;39(3):239-53
pubmed: 24308797
Nat Rev Gastroenterol Hepatol. 2012 Mar 06;9(5):286-94
pubmed: 22392290
Aliment Pharmacol Ther. 2004 Nov;20 Suppl 7:3-14
pubmed: 15521849
Mult Scler. 2008 Mar;14(2):237-42
pubmed: 17942511
BMC Gastroenterol. 2012 Nov 06;12:156
pubmed: 23130661
J Epidemiol Community Health. 1995 Dec;49(6):563-9
pubmed: 8596089
Biophys J. 2008 Jul;95(1):88-104
pubmed: 18339738
Dig Dis Sci. 2010 Apr;55(4):1090-7
pubmed: 20012484
IEEE Trans Biomed Eng. 2011 Dec;58(12):3491-5
pubmed: 21878406
Gastroenterology. 2007 Jan;132(1):397-414
pubmed: 17241888
Indian J Gastroenterol. 2014 Nov;33(6):530-6
pubmed: 25316170
Am J Gastroenterol. 2004 Dec;99(12):2405-16
pubmed: 15571589
Am J Gastroenterol. 2004 Apr;99(4):750-9
pubmed: 15089911
Gastroenterology. 1982 Nov;83(5):1002-7
pubmed: 6288506
Aliment Pharmacol Ther. 2002 Mar;16(3):603-12
pubmed: 11876716
Dig Dis Sci. 2011 Feb;56(2):330-8
pubmed: 21181441
Neurogastroenterol Motil. 2012 Nov;24(11):977-82
pubmed: 23057554
Dis Colon Rectum. 1967 May-Jun;10(3):222-8
pubmed: 6026805
Dis Colon Rectum. 1987 Feb;30(2):95-100
pubmed: 3803128
Gastroenterology. 1990 Jun;98(6):1538-42
pubmed: 2338192
Gut. 1992 Jun;33(6):818-24
pubmed: 1624166
Wiley Interdiscip Rev Syst Biol Med. 2016 Jan-Feb;8(1):69-85
pubmed: 26562482
Mayo Clin Proc. 1990 Jun;65(6):825-46
pubmed: 2164123
Gut. 1980 Feb;21(2):128-32
pubmed: 7380334

Auteurs

Raibatak Das (R)

Applied BioMath, Concord, MA, USA.

Lucia Wille (L)

Applied BioMath, Concord, MA, USA.

Liming Zhang (L)

Takeda Pharmaceutical Inc., Cambridge, MA, USA.

Chunlin Chen (C)

Takeda Pharmaceutical Inc., Cambridge, MA, USA.

Wendy Winchester (W)

Takeda Pharmaceutical Inc., Cambridge, MA, USA.

Jangir Selimkhanov (J)

Takeda Pharmaceutical Inc., Cambridge, MA, USA.

Jill Wykosky (J)

Takeda Pharmaceutical Inc., Cambridge, MA, USA.

Joshua F Apgar (JF)

Applied BioMath, Concord, MA, USA.

John M Burke (JM)

Applied BioMath, Concord, MA, USA.

Mark Rogge (M)

Takeda Pharmaceutical Inc., Cambridge, MA, USA.

Fei Hua (F)

Applied BioMath, Concord, MA, USA.

Majid Vakilynejad (M)

Takeda Pharmaceutical Inc., Cambridge, MA, USA. Majid.Vakilynejad@Takeda.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH